A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn’s Disease - Related Studies

A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn’s Disease

This study has been completed.

Study NCT00078611. Last updated on October 26, 2005. Information provided by Elan Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Crohn's Disease

2	Additional conditions recognized in this trial
		Crohn Disease

3	More general conditions related to this trial
		Digestive System Diseases
		Gastroenteritis
		Gastrointestinal Diseases
		Inflammatory Bowel Diseases
		Intestinal Diseases

4	Interventions listed in this trial
		Antegren(TM) (natalizumab)

5	Sponsors listed in this trial
		Elan Pharmaceuticals
		Biogen Idec